Therapy of other bacterial infections.
Cutaneous bacterial disease continues to account for a significant proportion of clinical visits. The continuing emergence of strains that are resistant to available antibacterial agents creates a challenge for dermatologists, who need to keep abreast of current treatment strategies. In this article, antibacterial regimens are presented for skin infections caused by organisms such as Staphylococcus, Streptococcus, Pseudomonas, Neisseria, Haemophilus ducreyi, Treponema pallidum, Bacillus anthracis, Yersinia pestis, Pasteurella multocida, Vibrio vulnificus, Actinomyces, and Nocardia.
Werlinger
Kelly D
KD
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Moore
Angela Yen
AY
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D015231:Sexually Transmitted Diseases, Bacterial / Q000188:drug therapy / Q000382:microbiology; D017192:Skin Diseases, Bacterial / Q000188:drug therapy* / Q000382:microbiology*
D000900:Anti-Bacterial Agents